Atnaujinkite slapukų nuostatas

El. knyga: Angiotensin II Receptor Blockade Physiological and Clinical Implications

Edited by , Edited by , Edited by , Edited by
Kitos knygos pagal šią temą:
Angiotensin II Receptor Blockade Physiological and Clinical ImplicationsDidesnis paveikslėlis
Kitos knygos pagal šią temą:

DRM apribojimai

  • Kopijuoti:

    neleidžiama

  • Spausdinti:

    neleidžiama

  • El. knygos naudojimas:

    Skaitmeninių teisių valdymas (DRM)
    Leidykla pateikė šią knygą šifruota forma, o tai reiškia, kad norint ją atrakinti ir perskaityti reikia įdiegti nemokamą programinę įrangą. Norint skaityti šią el. knygą, turite susikurti Adobe ID . Daugiau informacijos  čia. El. knygą galima atsisiųsti į 6 įrenginius (vienas vartotojas su tuo pačiu Adobe ID).

    Reikalinga programinė įranga
    Norint skaityti šią el. knygą mobiliajame įrenginyje (telefone ar planšetiniame kompiuteryje), turite įdiegti šią nemokamą programėlę: PocketBook Reader (iOS / Android)

    Norint skaityti šią el. knygą asmeniniame arba „Mac“ kompiuteryje, Jums reikalinga  Adobe Digital Editions “ (tai nemokama programa, specialiai sukurta el. knygoms. Tai nėra tas pats, kas „Adobe Reader“, kurią tikriausiai jau turite savo kompiuteryje.)

    Negalite skaityti šios el. knygos naudodami „Amazon Kindle“.

The relationship between angiotensin II and hypertension was established in 1898 when angiotensin II was shown to modulate systemic blood pressure. Over the intervening decades, a complete characterization of the renin-angiotensin system (RAS) has been achieved, and our understanding of its biochemistry and physiology has led to the directed development of agents such ·as ACE inhibitors and receptor antagonists capable of controlling hypertension. More recently, it was shown that angiotensin II is secreted within certain tissues and that these tissue-specific systems operate independently of the systemic RAS. The novel concept that angiotensin II regulates a number of cardiovascular processes that are unrelated to blood pressure has renewed the interest of both basic and clinical scientists in angiotensin II. The association between angiotensin II and cardiac growth, in particular, has indicated that therapies currently in use for hypertension may have direct application to the treatment of heart failure. The Manitoba Cardiovascular Forum on Angiotensin Receptor Blockade in Winnipeg was convened October 18-20, 1996 to examine the clinical and basic aspects of angiotensin receptor biology as they apply to hypertension and heart failure. In addition, the potential treatment of these conditions using specific angio­ tensin receptor antagonists was addressed within the context of their immediate therapeutic application and future potential.

Daugiau informacijos

Springer Book Archives
A. Pharmacological Interruption of Renin-Angiotensin in Hypertension.-
1. Pharmacological Interruption of the Renin System and the Kidney: Lessons
from Comparative Pharmacology.-
2. The Brain Renin-Angiotensin System and
Salt-Sensitive Hypertension.-
3. At1 Angiotensin Receptor Blockade and
Angiotensin-Converting Enzyme Inhibition: Effects on Vascular Remodeling and
Endothelial Dysfunction in SHR.-
4. Cellular Physiology of Angiotensin II
Receptors in Vascular Smooth Muscle Cells.-
5. Angiotensin II Enhanced the
Expression of Inhibitory Guanine Nucleotide Regulatory Protein in Vascular
Smooth Muscle Cells: Blockade by AT1 Antagonist.-
6. Comparison of the
Inhibitory Actions of Angiotensin AT1 Receptor Antagonists in the Peripheral
Vascular Bed.-
7. Angiotensin II Receptor Antagonists in Patients with Renal
Failure and on Hemodialysis.-
8. The Place of Angiotensin II Antagonists in
Relation to the Canadian Hypertension Society Guidelines.-
9. Translating
Clinical Guidelines for Management of Heart Failure and Hypertension into
Clinical Practice.-
10. Cough Induced by Pharmacological Modulation of the
Renin-Angiotensin-Aldosterone System. Angiotensin-Converting Enzyme
Inhibitors and Angiotensin II Receptor Antagonists.- B. Angiotensin Blockade
and Cardiovascular Disease.-
11. Angiotensin II Receptors AT1 and AT2: New
Mechanisms of Signaling and Antagonistic Effects of AT1 and AT2.-
12.
Angiotensin Receptor Antagonists and Cardiovascular Remodeling.-
13.
Intersubject Variability in the Pharmacokinetics of Losartan.-
14. Functional
Analysis of Tissue Renin-Angiotensin System Using Gain and Loss of Function
Approaches: In vivo Test of in vitro Hypothesis.-
15. Exploring the
Difference Between Angiotensin-Converting Enzyme Inhibitors and Angiotensin
II ReceptorAntagonists. A Focus on Bradykinin.-
16. Role of Cytokines in
Septic Cardiomyopathy.-
17. In Pursuit of Optimal Care and Outcomes for
Patients with Congestive Heart Failure: Insights from the Past Decade.-
18.
Atherosclerosis: Implications of Angiotensin II and the AT-1 Receptor.-
19.
Influence of AT1 Receptor Inhibition on Cardiac Function and Structure of
Diabetic Rats.-
20. Role of Myocardial Tissue Angiotensin (Ang.) II in
Cardiac Pathology.- C. Angiotensin Blockade and Cardiac Hypertrophy and Heart
Failure.-
21. Mechanical Stress, Local Renin-Angiotensin System and Cardiac
Hypertrophy. An Overview.-
22. Role of Renin-Angiotensin System in Cardiac
Hypertrophy and Failure.-
23. Effect of Angiotensin-Converting Enzyme
Inhibition and of Angiotensin II Receptor Blockade on the Development of
Cardiac Hypertrophy in Rats.-
24. Effects of Inhibition of
Angiotensin-Converting Enzyme on Myocardial and Myocyte Remodeling in Chronic
Volume Overload-Induced Cardiac Hypertrophy in the Dog.-
25. The Site of
Angiotensin Generation: Focus on the Heart.-
26. Angiotensin II-Mediated STAT
Signal Transduction: Studies in Neonatal Rat Cardiac Fibroblasts and CHO-K1
Cells Expressing At1A Receptors.-
27. Cardiac Angiotensin II Subtype 2
Receptor Signal Transduction Pathways: Embryonic Cardiomyocytes and Human
Heart.-
28. Angiotensin II Stimulates Contractility and C-fos Gene Expression
in Isolated Atrial Human Myocardium.-
29. Stimulation of the Na+/Ca2+
Exchanger by Angiotensin II.-
30. Developmental Regulation of the Cardiac
Renin-Angiotensin System: Expression and Association with Growth and
Apoptosis.-
31. Angiotensin II-Regulated Apoptosis in Cardiovascular
Remodeling.-
32. The Role of Angiotensin II in Stretch-Activated Signal
Transduction of the Normal, Hypertrophied, and FailingAdult Heart.- D.
Angiotensin Blockade And Remodeling Of Heart In Myocardial Infarction.-
33.
Role of Angiotensin II Receptor Blockade During Remodeling After Myocardial
Infarction.-
34. Local Angiotensin II and Tissue Repair Post-Myocardial
Infarction.-
35. Losartan Pretreatment Inhibits an Early Activation of Matrix
Metalloproteinases in Acute Myocardial Infarction.-
36. The Role of
Angiotensin II in Post-Translational Regulation of Fibrillar Collagens in
Fibrosed and Failing Rat Heart.-
37. Characteristics and Mechanisms of
Angiotensin II-Related Myocardial Damage.-
38. Comparison of Direct
Angiotensin II Receptor Blockade with Converting Enzyme Inhibition in the Rat
Model of Heart Failure.-
39. Effects of Captopril on Myocardial Oxidative
Stress Changes in Post-MI Rats.-
40. Role of Angiotensin in Angiogenesis and
Cardiac Fibrosis in Heart Failure.-
41. Role of Angiotensin II in Myocardial
Ischemia/Reperfusion Injury.-
42. Effects of Angiotensin II Receptor
Antagonist on Cardiac Remodeling in Cardiomyopathic Hamster Hearts.
Daugiau apie elektronines knygas Daugiau apie elektronines knygas
Pastovi nuoroda: https://www.kriso.lt/db/97814615574322e.html
Raktažodžiai: